美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

克律克斯生物制药

3.36

0.0000

成交量：- -

成交额：- -

市值：4.04亿

市盈率：-4.49

高：3.36

开：3.36

低：3.36

收：3.36

52周最高：5.98

52周最低：2.47

股本：1.20亿

流通股本：8,215.33万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.7491

每股收益(LYR):-1.4273

净资产收益率：--

总资产收益率：--

市净率：-7.46

市盈率(LYR):-2.35

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

克律克斯生物制药

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.keryx.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Keryx Biopharmaceuticals is biopharmaceutical company focused on the acquisition, development and commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/KERX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"KERX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KERX\",,,,,undefined,":{"symbol":"KERX","market":"US","secType":"STK","nameCN":"克律克斯生物制药","latestPrice":3.36,"timestamp":1575925200000,"preClose":3.36,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":82153320,"shares":120375926,"eps":-0.749112,"marketStatus":"退市","change":0,"latestTime":"12-09 16:00:00 EST","open":3.36,"high":3.36,"low":3.36,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.749112,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773993600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":964756800000,"exchange":"NASDAQ","adjPreClose":3.36,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KERX\",,,,,undefined,":{"symbol":"KERX","floatShares":82153320,"roa":"--","roe":"--","lyrEps":-1.427327,"shares":120375926,"dividePrice":0,"high":3.36,"amplitude":0,"preClose":3.36,"low":3.36,"week52Low":2.47,"pbRate":"-7.46","week52High":5.98,"institutionHeld":0.9467,"latestPrice":3.36,"eps":-0.749112,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.749112,"open":3.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KERX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"KERX","fiscalQuarterEnding":"2018/09","expectedEps":-0.13,"name":null,"time":"盘后","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2018-08-08","symbol":"KERX","expectedEps":-0.14,"name":"克律克斯生物制药","time":"盘前","type":"earning","dateTimestamp":1533700800000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2018-05-10","symbol":"KERX","fiscalQuarterEnding":"2018/03","expectedEps":-0.19,"name":null,"time":"盘前","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2018-02-07","symbol":"KERX","fiscalQuarterEnding":"2017/12","expectedEps":-0.18,"name":null,"time":"盘前","type":"earning","dateTimestamp":1517979600000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2017-11-07","symbol":"KERX","expectedEps":-0.17,"name":"克律克斯生物制药","time":"","type":"earning","dateTimestamp":1510030800000,"reportTimeType":"","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KERX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KERX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.keryx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0338},{"period":"3month","weight":-0.0305},{"period":"6month","weight":-0.0059},{"period":"1year","weight":0.1634},{"period":"ytd","weight":-0.0324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Keryx Biopharmaceuticals is biopharmaceutical company focused on the acquisition, development and commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.","exchange":"NASDAQ","name":"克律克斯生物制药","nameEN":"Keryx Biopharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KERX\",market:\"US\",,,undefined,":null}}